Baxter International Inc. (BAX) Stock Price, Quote & AI Analysis

Live BAX stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Baxter International Inc..

TradeVae provides AI-driven analysis and real-time market intelligence for Baxter International Inc. (BAX), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.

BAX
Baxter International Inc.
real-time
$0.00 +0.00 (+0.00%)
Open
17.400000
High
17.780000
Low
17.040000
Volume
6,354,808
VWAP
-
Market Cap
$8,580,116,782.68
52W Range
$15.73 - $32.68
P/E Ratio
-
EPS
-
Dividend Yield
216.61%
Debt/Equity
-
EV/EBITDA
-
Upcoming Earnings
Apr 29, 2026 Q1
Market
EPS Estimate: $0.4903
Revenue Estimate: $2,670,258,341.00
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

Baxter International Inc.'s fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

Baxter International Inc. Overview

Company information

Company Overview

Baxter International, Inc. engages in the provision of a portfolio of essential healthcare products including acute and chronic dialysis therapies, sterile intravenous (IV) solutions, infusion systems and devices, parenteral nutrition therapies, inhaled anesthetics, generic injectable pharmaceuticals, surgical hemostat and sealant products, surgical equipment, smart bed systems, patient monitoring and diagnostic technologies, and respiratory health devices. It operates through the following segments: Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. The Medical Products and Therapies segment includes sales of sterile IV solutions, infusion systems, administration sets, parenteral nutrition therapies and surgical hemostat, sealant, and adhesion prevention products. The Healthcare Systems and Technologies segment sells connected care solutions and collaboration tools, including smart bed systems, patient monitoring systems and diagnostic technologies, respiratory health devices and advanced equipment for the surgical space, including operating room integration technologies, precision positioning devices, and other accessories. The Pharmaceuticals segment focuses on the sales of specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL.

Company Details
Market Cap
$8.87B
Shares Outstanding
514,490,077
Weighted Shares Outstanding
516,252,514
CEO
Andrew P. Hider
Address
ONE BAXTER PARKWAY, DEERFIELD, IL, 60015
Employees
37,500
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Exchange
XNYS

Technical Indicators

Key technical analysis metrics and signals

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

Baxter International Inc. Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...